Incruse Ellipta 55 micrograms inhalation powder, pre-dispensed

Company:
GlaxoSmithKline (Ireland) Ltd
Status:
No Recent Update
Legal Category:
Product subject to medical prescription which may be renewed (B)
Active Ingredient(s):
Umeclidinium Bromide
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/14/922/001-003

55 microgram(s)

H01AC,H01AC03

Powder for Inhalation